The race to supply obesity drugs is so competitive that one early-stage startup is already striking a deal for commercial ...

With early phase 1 data now out in the wild, metabolic disease outfit Metsera is wasting no time locking down supplies of its ...

On Monday, Amneal Pharmaceuticals Inc (AMRX) stock saw a modest uptick, ending the day at $8.32 which represents a slight increase of $0.13 or 1.59% from the prior close of $8.19. The stock opened at ...

Amneal Pharmaceuticals (AMRX) and Metsera have entered into a collaboration agreement to enable the efficient development and ...

Amneal Pharmaceuticals has sued Colorado in an effort to block a state law requiring it to provide free generic EpiPens to ...

S hares of Amneal Pharmaceuticals AMRX, a commercial-stage company marketing generics as well as specialty pharmaceutical ...

A pharmaceutical corporation sued Colorado Friday in federal court aiming to bring a halt to a law approved in 2023, which ...

BRIDGEWATER, N.J., September 05, 2024--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company") and Shilpa Medicare Limited ("Shilpa") announced U.S ...

Commerce Minister Piyush Goyal invited American companies to invest in India's electronics, data infrastructure, and ...

Amneal Pharmaceuticals Inc (AMRX) stock saw a decline, ending the day at $8.52 which represents a decrease of $-0.18 or -2.07% from the prior close of $8.7. The stock opened at $8.67 and touched a low ...